Indo US Bio-Tech Ltd. engages in the research, development, production, marketing and sale of all types of agriculture seeds. Its products include vegetable seeds, cotton seeds, oil seeds, spices seeds, pulses seeds, and cereals seeds. The company was founded on February 4, 2004, and is headquartered in Ahmedabad, India.
Indo US Bio-Tech Dividend Announcement
• Indo US Bio-Tech announced a annually dividend of ₹0.25 per ordinary share which will be made payable on 2024-12-19. Ex dividend date: 2024-12-03
• Indo US Bio-Tech annual dividend for 2024 was ₹0.25
• Indo US Bio-Tech's trailing twelve-month (TTM) dividend yield is -%
Indo US Bio-Tech Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2024-12-03 | ₹0.25 | annually | 2024-12-19 |
| 2021-10-28 | ₹0.10 | annually | 2021-11-08 |
Indo US Bio-Tech Dividend per year
Indo US Bio-Tech Dividend Yield
Indo US Bio-Tech current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Indo US Bio-Tech stock? Use our calculator to estimate your expected dividend yield:
Indo US Bio-Tech Financial Ratios
P/E ratio44.36
PEG ratio0.44
P/B ratio7.41
ROE35.30%
Payout ratio0.00%
Current ratio5.74
Quick ratio2.52
Cash Ratio0.08
Indo US Bio-Tech Dividend FAQ
Does Indo US Bio-Tech stock pay dividends?
Indo US Bio-Tech does not currently pay dividends to its shareholders.
Has Indo US Bio-Tech ever paid a dividend?
No, Indo US Bio-Tech has no a history of paying dividends to its shareholders. Indo US Bio-Tech is not known for its dividend payments.
Why doesn't Indo US Bio-Tech pay dividends?
There are several potential reasons why Indo US Bio-Tech would choose not to pay dividends to their shareholders:
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Indo US Bio-Tech ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Indo US Bio-Tech has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Indo US Bio-Tech a dividend aristocrat?
Indo US Bio-Tech is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Indo US Bio-Tech a dividend king?
Indo US Bio-Tech is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Indo US Bio-Tech a dividend stock?
No, Indo US Bio-Tech is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Indo US Bio-Tech stocks?
To buy Indo US Bio-Tech you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.
Place an order: Use the brokerage's trading platform to place an order to buy Indo US Bio-Tech stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy Indo US Bio-Tech stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.